Expert for Media Profile
![Harris Goldstein](https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/413767e0-33fc-11ef-91ed-c34cd62813a0.jpg)
Infectious Diseases
Harris Goldstein, MD
- Professor of Pediatrics, Albert Einstein College of Medicine
- Associate Dean, Scientific Affairs, Children’s Hospital at Montefiore
- Professor, Department of Pediatrics (Pediatric Allergy & Immunology)
- Professor, Department of Microbiology & Immunology
- Senior Associate Dean for Scientific Affairs
- Charles Michael Chair in Autoimmune Diseases
- Director, Einstein-Rockefeller-CUNY Center for AIDS Research
Area of Expertise
View Faculty ProfileExpert Summary
Dr. Goldstein’s NIH-funded research centers on developing agents to amplify the capacity of the immune system to control HIV infection and achieve a functional cure for the disease. In seeking to “weaponize” the immune system to cure HIV, his lab uses molecular, cellular, and biochemical approaches, including CAR-T cells and the novel treatment strategy developed by Dr. Almo at Einstein for selective T cell amplification called synTac (synthetic T-cell activation).
Dr. Goldstein also studies the effects of HIV on the brain and central nervous system and the role of illicit drug use in accelerating HIV infection and causing neurological dysfunction. He is using mouse models developed in his lab to evaluate HIV vaccine candidates and other therapeutics.
As director of the NIH-funded Einstein-Rockefeller-CUNY Center for AIDS Research, Dr. Goldstein coordinates collaborations by more than 150 investigators from the three institutions. They are working to prevent HIV, to improve health outcomes for people living with HIV, and to find a cure for the HIV infection. In his role as associate dean of scientific resources at Einstein, he assesses new technologies for Einstein’s labs and oversees the work of over 40 shared scientific facilities.